Skip to content
Recall Observatory FDA recall evidence

Drug product

Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple-dose vials per Carton, NDC 70069-161-01.

D-0238-2026

November 26, 2025

Class III

Product summary

Firm
SOMERSET THERAPEUTICS LLC
Event
Event 98063
Status
Ongoing
Classification
Class III
Quantity
71,310 10mL vials
Official record key
drug-enforcement:D-0238-2026

Official wording

Reason: Subpotent product:out of specification assay results observed during long term stability testing.

Code information: Lot#: A250043, EXP Date 06/30/2026

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent